Clinical Trial Update: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment [Phase 2]

View source ↗

Summary

A Phase II trial evaluating first-line doxycycline for marginal zone lymphoma of the ocular adnexa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma of the Ocular Adnexa

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Marginal Zone Lymphoma of Ocular Adnexal | Phase 2 | Status: COMPLETED